Clinical trial
Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating…
NCT00430183 · Alliance for Clinical Trials in Oncology, Other · Active, not recruiting
Key facts
| NCT number | NCT00430183 |
|---|---|
| Title | Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer |
| Official title | A Randomized Phase III Study of Neo-Adjuvant Docetaxel and Androgen Deprivation Prior to Radical Prostatectomy Versus Immediate Radical Prostatectomy in Patients With High-Risk, Clinically Localized Prostate Cancer |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH Eastern Cooperative Oncology Group NCIC Clinical Trials Group SWOG Cancer Research Network |
| Status | Active, not recruiting |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug, Procedure |
| Interventions | docetaxel, LHRH agonist, surgery |
| Enrollment | 788 |
| Start date | May 8, 2007 |
| Primary completion | Oct 2, 2018 |
| Completion | Oct 1, 2030 |
| First posted | Feb 1, 2007 |
| Last update posted | Feb 9, 2023 |
| Countries | Canada, United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: